Published in Ann Intern Med on June 01, 1967
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med (1970) 4.41
Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis (2006) 3.87
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis (2011) 2.78
Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med (1970) 2.13
Arrival of chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl Trop Dis (2014) 1.95
Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale J Biol Med (1970) 1.45
Contrasting spatial distribution and risk factors for past infection with scrub typhus and murine typhus in Vientiane City, Lao PDR. PLoS Negl Trop Dis (2010) 1.19
Dengue epidemic in Malaysia: Not a predominantly urban disease anymore. BMC Res Notes (2011) 1.18
Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis (2012) 0.96
Dengue fever in a Western United States City. West J Med (1977) 0.81
Orientia tsutsugamushi Strain Ikeda Ankyrin Repeat-Containing Proteins Recruit SCF1 Ubiquitin Ligase Machinery via Poxvirus-Like F-Box Motifs. J Bacteriol (2015) 0.78
Zoonotic infections in military scout and tracker dogs in Vietnam. Infect Immun (1972) 0.78
Use of eschar swabbing for the molecular diagnosis and genotyping of Orientia tsutsugamushi causing scrub typhus in Quang Nam province, Vietnam. PLoS Negl Trop Dis (2017) 0.75
Infectious diseases. Annual review of significant publications. Postgrad Med J (1968) 0.75
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Flaviviridae. Intervirology (1985) 3.06
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Bunyaviridae. Intervirology (1980) 2.53
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32
Togaviridae. Intervirology (1985) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71
Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69
Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67
Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66
Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64
The proteins of Japanese encephalitis virus. Virology (1971) 1.63
Cerebral malaria. JAMA (1967) 1.62
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Lymphogranuloma venereum. I. Comparison of the Frei test, complement fixation test, and isolation of the agent. J Infect Dis (1969) 1.52
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38
Partial purification and characterization of a dengue virus soluble complement-fixing antigen. J Immunol (1970) 1.37
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30
Dengue virions and antigens in brain and serum of infected mice. J Virol (1970) 1.30
Human immunoglobulin specificity after group B arbovirus infections. Infect Immun (1972) 1.29
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis (1983) 1.27
Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect Immun (1980) 1.27
Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study. Am J Clin Nutr (1976) 1.26
Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun (1973) 1.26
Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. Am J Trop Med Hyg (1966) 1.25
RNA fingerprinting as a method for distinguishing dengue 1 virus strains. Am J Trop Med Hyg (1983) 1.25
Togaviridae. Intervirology (1978) 1.24
Comparison of dengue-2 and dengue-3 virus strains by neutralization tests and identification of a subtype of dengue-3. Am J Trop Med Hyg (1972) 1.23
Assay of arbovirus neutralizing antibody by micro methods. Trans R Soc Trop Med Hyg (1969) 1.21
Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun (1972) 1.21
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis (1984) 1.20
Enteritis and gastritis in young asymptomatic Pakistani men. Am J Dig Dis (1966) 1.19
Swine influenza A at Fort Dix, New Jersey (January-February 1976). II. Transmission and morbidity in units with cases. J Infect Dis (1977) 1.17
Detection of dengue cell-surface antigens by peroxidase-labeled antibodies and immune cytolysis. Infect Immun (1974) 1.16
Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am J Trop Med Hyg (1987) 1.13
The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab (2000) 1.12
Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg (1984) 1.11
Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegypti. Am J Trop Med Hyg (1982) 1.10
Recurrence of epidemic dengue hemorrhagic fever in an insular setting. Am J Trop Med Hyg (1969) 1.09
Malaria hepatitis. Mil Med (1967) 1.09
An insular outbreak of dengue hemorrhagic fever. I. Epidemiologic observations. Am J Trop Med Hyg (1968) 1.08
The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J (2000) 1.05
Complement fixation blocking activity of anti-dengue IgM antibody. J Immunol (1972) 1.05
Cache Valley virus in the Del Mar Va Peninsula. I. Virologic and serologic evidence of infection. Am J Trop Med Hyg (1970) 1.02
Ecology of arboviruses in a Maryland freshwater swamp. 3. Vertebrate hosts. Am J Epidemiol (1972) 1.01
Bunyaviruses and bunyaviridae. Intervirology (1974) 1.01
Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. Virology (1970) 0.99
Membrane-bound proteins of Japanese encephalitis virus-infected chick embryo cells. Virology (1972) 0.98
Specificity and sensitivity of radioimmunoassay for hepatitis B antigen. Appl Microbiol (1974) 0.97
Mosquito vectors of dengue viruses in South Vietnam. Am J Trop Med Hyg (1969) 0.97
Dimethyl sulfoxide enhancement of phlebotomus fever virus plaque formation. Am J Trop Med Hyg (1979) 0.96
Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect Immun (1972) 0.93
Chikungunya disease. Am J Trop Med Hyg (1968) 0.92
Family with hepatitis-associated antigen. Spectrum of liver pathology. JAMA (1971) 0.92
Potential of polymer microencapsulation technology for vaccine innovation. Vaccine (1994) 0.92
Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol (1971) 0.90
RNA polymerase in group B arbovirus (dengue-2) infected cells. Brief report. Arch Gesamte Virusforsch (1973) 0.89
Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers. JAMA (1974) 0.89
Growth hormone response patterns to sex hormone administration in growth retardation. Am J Med Sci (1970) 0.88
Observations on fevers of unknown origin in the Rephblic of Vietnam. Mil Med (1969) 0.88
Comparison of the virion polypeptides of group B arboviruses. Infect Immun (1972) 0.87
Influence of cell type and virus upon virus-specific immune cytolysis. Infect Immun (1975) 0.86
Method for extracting viral hemagglutination-inhibiting antibodies from the nonspecific inhibitors of serum. Appl Microbiol (1970) 0.86
Virion and soluble antigens of japanese encephalitis virus. Infect Immun (1975) 0.86
Protein synthesis in Japanese encephalitis virus-infected cells. Virology (1973) 0.85
Adenovirus vaccines in military recruit populations: a cost-benefit analysis. J Infect Dis (1973) 0.85
Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. Biochemistry (2001) 0.85
Flexion contracture in adrenal insufficiency. Arch Phys Med Rehabil (1968) 0.85
Kaeng Khoi virus from naturally infected bedbugs (cimicidae) and immature free-tailed bats. Bull World Health Organ (1976) 0.84
Recovery of dengue-2 virus from Aedes aegypti in Colombia. Am J Trop Med Hyg (1973) 0.84
An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol (1972) 0.83